<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03802032</url>
  </required_header>
  <id_info>
    <org_study_id>Ahmadu Bello University</org_study_id>
    <nct_id>NCT03802032</nct_id>
  </id_info>
  <brief_title>Topical Analgesia for Pain Relief in Hysterosalpingography</brief_title>
  <acronym>HSG</acronym>
  <official_title>Effect of Topical Xylocaine for Pain Relief During Hysterosalpingography Among Infertile Women in Zaria, Nigeria: A Randomised Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ahmadu Bello University Teaching Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ahmadu Bello University Teaching Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will involve giving topical analgesia or placebo and then assessing pain and&#xD;
      satisfaction during and after the procedure in order to see wed to the placebo.hether the&#xD;
      topical analgesia has helped in decreasing pain associated with the procedure and also&#xD;
      whether it has increasedd satisfaction with the procedure compar&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      STUDY DESIGN:&#xD;
&#xD;
      The study will be a double blind randomized controlled trial. Group A:The study group will be&#xD;
      given topical Xylocaine (2% Lidocaine) before the procedure.&#xD;
&#xD;
      Group B:The control group will be given topical K-Y jelly (water based lubricant) before the&#xD;
      procedure.&#xD;
&#xD;
      The participants and the radiologist will be blinded at the point of drug administration.&#xD;
&#xD;
      SAMPLE SIZE DETERMINATION:&#xD;
&#xD;
      The formula below was used to calculate the sample size n= (Zα + Zβ)2S2 d2&#xD;
&#xD;
      Assuming a difference in mean pain score among groups of 1.5 and using a standard deviation&#xD;
      of of 3.15.&#xD;
&#xD;
      Zα = standard normal deviate. Zβ = power = 95% = 1.64. S = standard deviation = 3.1. D = mean&#xD;
      difference in pain score = 1.5 n = (1.96 + 1.64)2 x 3.12 1.52&#xD;
&#xD;
      n = 55 Sample size per group will be rounded up to 60&#xD;
&#xD;
      SAMPLING APPROACH:&#xD;
&#xD;
      A probability sampling method will be used. Simple random sampling using a computer generated&#xD;
      table of random numbers will be used. The WINPEPI version 11.65 software will generate the&#xD;
      table of random numbers. The numbers 001-140 will be randomly allocated to two groups A and&#xD;
      B. Group A will be the study group and group B will be the control group (see appendix). Each&#xD;
      number from the table of random numbers will be copied on separate paper and then sealed in a&#xD;
      brown envelope. The envelopes will then be kept inside a box after shuffling.&#xD;
&#xD;
      Each patient will be allocated to the group that the number she picks corresponds to on the&#xD;
      computer printout. The numbers were made up to 140 to make up for patients that may&#xD;
      eventually drop out from the study.&#xD;
&#xD;
      .&#xD;
&#xD;
      SAMPLING RECRUITEMENT:&#xD;
&#xD;
      Women that fulfil the inclusion criteria will be recruited from radiology department as they&#xD;
      present for Hysterosalpingogram. After obtaining a written consent, participants will be&#xD;
      requested to pick one of the brown envelopes which will contain the randomization group.&#xD;
&#xD;
      BLINDING The drugs to be used (K-Y Jelly and Xylocaine gel) are identical.&#xD;
&#xD;
      DATA COLLECTION METHOD:&#xD;
&#xD;
      An informed written consent will be obtained from participants. Psychological support will be&#xD;
      given to the participant by a nurse after the procedure has been explained to the&#xD;
      participant. A questionnaire will then be filled. The participant will then be requested to&#xD;
      pick an envelope that represents the study number. A detailed explanation about the VAS and&#xD;
      its application was given personally to each woman before the procedure. An interviewer&#xD;
      administered questionnaire will be used to obtain information on socio-demographic&#xD;
      characteristics, reproductive profile, previous history of the procedure and experience with&#xD;
      analgesia.&#xD;
&#xD;
      The analgesic or placebo will be applied to the cervix (15ml) using a vaginal applicator 10&#xD;
      minutes before the procedure.&#xD;
&#xD;
      The procedure will then be done using standard clinical protocol. The pain rating scale will&#xD;
      be used to evaluate pain during from zero (no pain) to ten (worst possible pain) will be&#xD;
      explained to the client. The visual scale comparison to happy, glum, sad and horrified faces&#xD;
      will also be explained to the patient.&#xD;
&#xD;
      Pain assessment will be done during the procedure at the following steps:&#xD;
&#xD;
        1. After application of speculum.&#xD;
&#xD;
        2. After cervical manipulation (application of tenaculum and catheter).&#xD;
&#xD;
        3. After filling the uterus with contrast medium.&#xD;
&#xD;
        4. After withdrawal of speculum and catheter.&#xD;
&#xD;
        5. Thirty minutes after completing the procedure.&#xD;
&#xD;
      The Likert scale will be used to assess patient satisfaction following pain management.&#xD;
&#xD;
      .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2019</start_date>
  <completion_date type="Actual">December 22, 2019</completion_date>
  <primary_completion_date type="Actual">December 22, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A randomised controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
    <masking_description>Double blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pain perception</measure>
    <time_frame>witthin 45 minutes of the procedure</time_frame>
    <description>The pain score based on visual pain scale that assesses pain perception. It is a scale of 0 to 10.&#xD;
0 = absence of pain.&#xD;
= discomfort&#xD;
= mild pain.&#xD;
= annoying pain.&#xD;
= nagging pain.&#xD;
= distressing pain.&#xD;
= miserable.&#xD;
= intense&#xD;
= Dreadful.&#xD;
= worse possible&#xD;
= unbearable</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patients Satisfaction with procedure</measure>
    <time_frame>witthin 45 minutes of the procedure</time_frame>
    <description>Satisfaction with the procedure based on Likert scale. The scale is from 1 to 5.&#xD;
= Very dissatisfied.&#xD;
= Dissatisfied..&#xD;
= Neither satisfied nor dissatisfied.&#xD;
= Satisfied.&#xD;
= Very satisfied.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Infertility, Female</condition>
  <arm_group>
    <arm_group_label>Study Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15g of Topical Xylocaine gel</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>15g of KY Jelly</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine Gel</intervention_name>
    <description>topical lidocaine gel</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>KY jelly</intervention_name>
    <description>topical KY jelly</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All women that are sent in to the department of radiology for Hysterosalpingogram as&#xD;
             part of evaluation for infertility that give consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women that present for hysterosalpingography for other indications apart from&#xD;
             infertility and those that have history of allergy to xylocaine and/or K-Y jelly.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>based on biological gender</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anisah Yahya, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ahmadu Bello University Zaria</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ahmadu Bello University Teaching Hospital Shika-Zaria</name>
      <address>
        <city>Zaria</city>
        <state>Kaduna</state>
        <zip>PMB 06</zip>
        <country>Nigeria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Nigeria</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>January 10, 2019</study_first_submitted>
  <study_first_submitted_qc>January 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 14, 2019</study_first_posted>
  <last_update_submitted>August 14, 2020</last_update_submitted>
  <last_update_submitted_qc>August 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ahmadu Bello University Teaching Hospital</investigator_affiliation>
    <investigator_full_name>Anisah Yahya</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>infertility</keyword>
  <keyword>hysterosalpingography</keyword>
  <keyword>pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>obtained data and result will be shared</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>within 6 months of completion</ipd_time_frame>
    <ipd_access_criteria>free</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

